Third Point 13F holdings, Q3 2010
Holdings as of September 30, 2010 · filings on SEC EDGAR · latest filing →
Third Point disclosed 26 US equity positions worth $777.5m in its Q3 2010 13F filing. The largest position was POTASH CORP SASK INC at 18.5% of the reported book, followed by ALCON INC and PHH CORP. Against the Q2 2010 filing, it opened 12 new positions, added to 1 and reduced 4 among the top 26 holdings.
What did Third Point own in Q3 2010? Top 26 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2010 |
|---|---|---|---|---|---|---|---|
| 1 | POTASH CORP SASK INC | 18.5% | $144.0m | 1,000,000 | – | new | |
| 2 | ALCON INC | 15.0% | $116.8m | 700,000 | 0% | held | |
| 3 | PHH CORP | 9.5% | $73.7m | 3,500,000 | -16% | reduced | |
| 4 | CIT GROUP INC | 8.1% | $63.3m | 1,550,000 | -37% | reduced | |
| 5 | LIBERTY MEDIA CORP NEW INT | 7.1% | $54.8m | 4,000,000 | -20% | reduced | |
| 6 | AAPL APPLE INC | Technology | 5.5% | $42.6m | 150,000 | – | new |
| 7 | NXPI NXP SEMICONDUCTORS N V | Technology | 4.9% | $37.8m | 3,050,000 | – | new |
| 8 | ASPEN TECHNOLOGY INC | 4.7% | $36.3m | 3,500,000 | 0% | held | |
| 9 | DEPOMED INC | 3.9% | $30.4m | 6,790,000 | 0% | held | |
| 10 | NABI BIOPHARMACEUTICALS | 2.7% | $20.9m | 4,350,100 | -5% | reduced | |
| 11 | ORIT ORITANI FINL CORP DEL | 2.6% | $20.4m | 2,043,100 | – | new | |
| 12 | PHH CORP | 2.3% | $17.5m | 15,000,000 | 0% | held | |
| 13 | CAREFUSION CORP | 2.2% | $17.4m | 700,000 | – | new | |
| 14 | XERIUM TECHNOLOGIES INC | 2.2% | $17.1m | 1,294,505 | -0% | held | |
| 15 | GLD SPDR GOLD TRUST GOLD | 1.9% | $14.7m | 115,000 | – | new | |
| 16 | NTRS NORTHERN TR CORP | Financial Services | 1.9% | $14.5m | 600,000 | – | new |
| 17 | ABRAXAS PETE CORP | 1.6% | $12.7m | 4,801,054 | 0% | held | |
| 18 | KKR & CO L P DEL | 1.6% | $12.7m | 1,200,000 | – | new | |
| 19 | BIOFUEL ENERGY CORP | 1.4% | $11.1m | 5,578,800 | 0% | held | |
| 20 | SIX FLAGS ENTMT CORP NEW | 1.0% | $7.5m | 171,127 | – | new | |
| 21 | EMMIS COMMUNICATIONS CORP | 0.7% | $5.2m | 321,057 | 49% | added | |
| 22 | LIGAND PHARMACEUTICALS INC | 0.4% | $3.2m | 2,007,378 | 0% | held | |
| 23 | ONEIDA FINL CORP MD | 0.3% | $2.3m | 305,600 | – | new | |
| 24 | AIG AMERICAN INTL GROUP INC | Financial Services | 0.1% | $444.0k | 200,000 | – | new |
| 25 | AMED AMEDISYS INC | 0.0% | $94.0k | 200,000 | – | new | |
| 26 | VANTAGE DRILLING COMPANY *W EXP 05/24/201 | 0.0% | $38.0k | 1,875,000 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.